Activity value 76china Supplier,Last transaction date:
2026-03-25
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for yichang sanxia pharmaceuticals co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 29 transactions, with a transaction quantity of 24223.82 and a transaction weight of 98131.7.
Suppliers
yichang sanxia pharmaceuticals co.ltd.
Buyers
m s glaxosmithkline pakistan ltd.
POLs
——
PODs
kapw
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
10423.639942
Hs code
29419090
Product tags
raw material,r pharm,drum,drap,price,unit,neomycin sulphate
Product description
RAW MATERIAL FOR PHARMACEUTICAL INDUSTRY NEOMYCIN SULPHATE BP/USP/EP QTY : 25KG PER 8 DRUM. UNIT PRICE 51 PER KG DRAP NOC # IP 646990 / A093EA. DT:28-02-2026
Expand
Trade date
2026/02/20
B/L No.
3747123
Suppliers
yichang sanxia pharmaceuticals co.ltd.
Buyers
s kant healthcare ltd.
yichang sanxia pharmaceuticals co.ltd. is china Supplier,
and primarily engages in the import and export business of products such as neomycin sulphate,drum,pharmaceutical raw material.
According to the 52wmb.com global trade database, as of 2026-03-25, the company has completed 1510 international trades,
with its main trading regions covering india,united states,pakistan etc.
The core products include HS29419050,HS29419090,HS29419000 etc,
often transported via shanghai,port shanghai cn, port sgsin etc,
and its main trading partners are bimeda inc,glaxosmithkline pharma gmbh,glaxosmithkline paksitan ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on yichang sanxia pharmaceuticals co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.